Anyone considering 5-Amino-1MQ should discuss safer, evidence-based options with a qualified provider instead of relying on online protocols or research-use products
Global and societal implications of the diabetes epidemic
In the pivotal SURPASS-2 trial (n=1,879), tirzepatide at all doses (5 mg, 10 mg, 15 mg) demonstrated both non-inferiority and superiority to semaglutide 1 mg injection for A1C reduction (-2.01% to -2.30% vs -1.86%) and body weight loss (-7.6 to -12.4 kg vs -5.7 kg)
Sometimes this requires pre-authorization, a doctor may try omeprazole or pantoprazole first, so that insurance covers the Dexilant which is better (but again, its not the first drug prescribed)
Peivandi, S., Karimpour, A., and Moslemizadeh, N